Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-037538

Director sold 30,000 shares at $0.57 ($17,100)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WHITFIELD ROY A Director 2023-06-14 Sale 10b5-1 −30,000 $0.57 $17,100 216,250 D: show line 1 in the form
Open-market sales · 30,000 sh · avg $0.57 · $17,100
Loading xslF345X04/doc4.xml…